Benjamin Edwards’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$796K Buy
2,583
+124
+5% +$38.5K 0.01% 889
2026
Q2
$689K Buy
2,459
+58
+2% +$15.2K 0.01% 948
2026
Q1
$641K Buy
2,401
+336
+16% +$91K 0.01% 904
2025
Q4
$518K Buy
2,065
+931
+82% +$247K 0.01% 943
2025
Q3
$326K Buy
+1,134
New +$304K ﹤0.01% 1074
2024
Q3
– Sell
-85
Closed -$17K – 1149
2024
Q2
$17K Buy
85
+10
+13% +$2.03K ﹤0.01% 597
2024
Q1
$16K Buy
+75
New +$16.5K ﹤0.01% 600
2023
Q2
– Sell
-30
Closed -$6K – 702
2023
Q1
$6K Hold
30
– – ﹤0.01% 617
2022
Q4
$6K Hold
30
– – ﹤0.01% 627
2022
Q3
$5K Sell
30
-56
-65% -$11.5K ﹤0.01% 614
2022
Q2
$17K Sell
86
-141
-62% -$30.1K 0.01% 534
2022
Q1
$51K Sell
227
-49
-18% -$11.5K 0.01% 452
2021
Q4
$74K Buy
+276
New +$68.3K 0.02% 386

Other funds holding LH

Benjamin Edwards's LH Position: Q3 2026 in Review

Benjamin Edwards increased its Labcorp (LH) stake by 5% in Q3 2026, buying an estimated $38.5K and bringing the position to 2,583 shares worth $796K. The position accounts for 0.01% of the portfolio, ranked #889.

Benjamin Edwards first reported a position in LH in Q4 2021 and has held it in 13 quarters since. 925 funds tracked by Wall St. Rank hold LH as of Q3 2026.

  • Benjamin Edwards held 2,583 shares of Labcorp worth $796K as of Q3 2026.
  • Benjamin Edwards bought 124 Labcorp shares in Q3 2026, an estimated $38.5K.
  • Labcorp made up 0.01% of Benjamin Edwards's portfolio in Q3 2026, its #889 holding.
  • Benjamin Edwards first reported a position in Labcorp in Q4 2021 and has held it in 13 quarters since.
  • 925 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.

Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.